(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Moon rush: These private spacecraft will attempt lunar landings in 2026 - 2NASA’s history-making moon mission aims to send the first woman and person of color to deep space
- 3From Certificate to Dollars: College Majors with Extraordinary Monetary Prizes
- 4Flying without a Real ID? That'll soon cost you $45, TSA says.
- 5NASA's SPHEREx telescope completes its 1st cosmic map of the entire sky and it's stunning!
- NASA shares first photos of Earth taken by Artemis II
- The Best 15 Applications for Efficiency and Association
- Inflammatory Merz remarks on migrants' violence against women slammed
- Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials
- Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- Major railway disruptions persist as Germany braces for more snow
- China's 1st reusable rocket explodes in dramatic fireball during landing after reaching orbit on debut flight
- Find the Abilities Required for Advanced Advertising Position
- 5 Superstar Couples That Motivate Relationship Objectives
